Sony Biotechnology

Sony Biotechnology is a specialized provider of flow cytometry and cell isolation systems, operating within the life sciences tools and diagnostics sector. The company leverages its engineering heritage from its parent corporation to develop high-performance, reliable instrumentation like the FP7000 Spectral Cell Sorter and ID7000 Spectral Cell Analyzer, aimed at simplifying complex workflows for researchers. Its business model is centered on selling capital equipment, associated reagents, and software services to academic, biopharma, and clinical labs. While a subsidiary of the public Sony Group, it operates as a commercial, revenue-generating entity within the broader biotechnology tools market.

Spectral flow cytometry and cell sorting instrumentation, including analyzers (ID7000), sorters (FP7000, MA900, SH800S), a closed cell isolation system for therapy (CGX10), and a cloud-based analysis software platform (SFA).

Operates in a highly competitive market dominated by BD Biosciences and Beckman Coulter, with strong competition in spectral technology from Cytek Biosciences. Also competes with companies like Miltenyi Biotec and Bio-Rad in the cell sorting and therapy manufacturing space.